Literature DB >> 21976761

Novel one-step method for detection and isolation of active-toxin-producing Clostridium difficile strains directly from stool samples.

Charles Darkoh1, Herbert L Dupont, Heidi B Kaplan.   

Abstract

The alarming emergence of hypervirulent strains of Clostridium difficile with increased toxin production, severity of disease, morbidity, and mortality emphasizes the need for a culture method that permits simultaneous isolation and detection of virulent strains. The C. difficile toxins A and B are critical virulence factors, and strains can either be toxin-producing (virulent) or non-toxin-producing (nonvirulent). Strains that are isolated from human infections generally produce either toxin A or toxin B or both. The methods currently available for culturing C. difficile do not differentiate strains that produce active toxins from strains that do not produce toxins or produce inactive toxins. As a result, the identification and isolation of toxin-producing strains from stool is currently a two-step process. First, the stool is plated on a selective medium, and then suspected colonies are analyzed for toxin production or the presence of the toxin genes. We describe here a novel selective and differential culture method, the Cdifftox plate assay, which combines in a single step the specific isolation of C. difficile strains and the detection of active toxin. This assay was developed based on our recent finding that the A and B toxins of C. difficile cleave chromogenic substrates that have stereochemical characteristics similar to their natural substrate, UDP-glucose. The Cdifftox plate assay is shown here to be extremely accurate (99.8% effective) in detecting toxin-producing strains through the analysis of 528 C. difficile isolates selected from 50 tissue culture cytotoxicity assay-positive clinical stool samples. The Cdifftox plate assay advances and improves the culture approach such that only C. difficile strains will grow on this agar, and virulent strains producing active toxins can be differentiated from nonvirulent strains, which do not produce active toxins. This new method reduces the time and effort required to isolate and confirm toxin-producing C. difficile strains.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21976761      PMCID: PMC3232957          DOI: 10.1128/JCM.01033-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  48 in total

1.  Growth of Clostridium difficile and production of toxins A and B in complex and defined media.

Authors:  S C Haslam; J M Ketley; T J Mitchell; J Stephen; D W Burdon; D C Candy
Journal:  J Med Microbiol       Date:  1986-06       Impact factor: 2.472

2.  Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies.

Authors:  D M Lyerly; C J Phelps; J Toth; T D Wilkins
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

Review 3.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

4.  Glucosylation of Rho proteins by Clostridium difficile toxin B.

Authors:  I Just; J Selzer; M Wilm; C von Eichel-Streiber; M Mann; K Aktories
Journal:  Nature       Date:  1995-06-08       Impact factor: 49.962

5.  Toxin production by Clostridium difficile in a defined medium with limited amino acids.

Authors:  K Yamakawa; S Kamiya; X Q Meng; T Karasawa; S Nakamura
Journal:  J Med Microbiol       Date:  1994-11       Impact factor: 2.472

6.  Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B.

Authors:  S T Dillon; E J Rubin; M Yakubovich; C Pothoulakis; J T LaMont; L A Feig; R J Gilbert
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

7.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

8.  Purification and characterization of Clostridium difficile toxin.

Authors:  R D Rolfe; S M Finegold
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

9.  The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins.

Authors:  I Just; M Wilm; J Selzer; G Rex; C von Eichel-Streiber; M Mann; K Aktories
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

10.  Effects of Clostridium difficile toxins given intragastrically to animals.

Authors:  D M Lyerly; K E Saum; D K MacDonald; T D Wilkins
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

View more
  10 in total

Review 1.  A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics.

Authors:  John D Perry
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

Review 2.  Clostridium difficile.

Authors:  Scott Curry
Journal:  Clin Lab Med       Date:  2010-03       Impact factor: 1.935

3.  Emergence of Clinical Clostridioides difficile Isolates With Decreased Susceptibility to Vancomycin.

Authors:  Charles Darkoh; Kadiatou Keita; Chioma Odo; Micah Oyaro; Eric L Brown; Cesar A Arias; Blake M Hanson; Herbert L DuPont
Journal:  Clin Infect Dis       Date:  2022-01-07       Impact factor: 9.079

4.  Colonic immunopathogenesis of Clostridium difficile infections.

Authors:  Charles Darkoh; Bradley P Turnwald; Hoonmo L Koo; Kevin W Garey; Zhi-Dong Jiang; Samuel L Aitken; Herbert L DuPont
Journal:  Clin Vaccine Immunol       Date:  2014-01-29

5.  Evaluation of the chromogenic agar chromID C. difficile.

Authors:  Catherine Eckert; Béatrice Burghoffer; Valérie Lalande; Frederic Barbut
Journal:  J Clin Microbiol       Date:  2012-12-26       Impact factor: 5.948

6.  Toxin synthesis by Clostridium difficile is regulated through quorum signaling.

Authors:  Charles Darkoh; Herbert L DuPont; Steven J Norris; Heidi B Kaplan
Journal:  MBio       Date:  2015-02-24       Impact factor: 7.867

7.  Evaluation of a chromogenic culture medium for the detection of Clostridium difficile.

Authors:  John Jeongseok Yang; You Sun Nam; Min Jin Kim; Sun Young Cho; Eunkyung You; Yun Soo Soh; Hee Joo Lee
Journal:  Yonsei Med J       Date:  2014-07       Impact factor: 2.759

8.  Accessory Gene Regulator-1 Locus Is Essential for Virulence and Pathogenesis of Clostridium difficile.

Authors:  Charles Darkoh; Chioma Odo; Herbert L DuPont
Journal:  MBio       Date:  2016-08-16       Impact factor: 7.867

9.  Bile salt inhibition of host cell damage by Clostridium difficile toxins.

Authors:  Charles Darkoh; Eric L Brown; Heidi B Kaplan; Herbert L DuPont
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

10.  High rate of Clostridium difficile among young adults presenting with diarrhea at two hospitals in Kenya.

Authors:  Micah O Oyaro; Kimberly Plants-Paris; Dayna Bishoff; Paul Malonza; Christopher S Gontier; Herbert L DuPont; Charles Darkoh
Journal:  Int J Infect Dis       Date:  2018-06-28       Impact factor: 3.623

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.